 Smokers showed cortical thinning in multiple brain regions relative to Non-Smokers.  Greater cigarette pack years was related to thinner cortex in multiple regions.
Introduction
The link between cigarette smoking and markedly increased risk for pulmonary, cardiac, and vascular disease as well as for multiple forms of cancer in humans is essentially indisputable (CDC, 2004) . A growing body of evidence also indicates that smoking, in otherwise healthy individuals, is associated with neurobiological and neurocognitive abnormalities that are not directly related to the foregoing diseases (Azizian et al., 2009; Durazzo et al., 2014a; Durazzo et al., 2010; Durazzo et al., 2017; Sharma and Brody, 2009 ). Most magnetic resonance (MR) studies investigating the neurobiological consequences of cigarette smoking have focused on volume/density of cortical gray matter (GM) and/or subcortical nuclei (see Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 2016 for review) . Smaller volumes or lower density in dorsal and ventromedial prefrontal cortex, orbitofrontal cortex, insula, thalamus, and cerebellum were A C C E P T E D M A N U S C R I P T the most consistently reported findings (Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 2016) ; structural abnormalities in these regions are also apparent in alcohol and substance use disorders (see Buhler and Mann, 2011; Cadet et al., 2014 for review) The anterior frontal, insular, and subcortical regions that show structural abnormalities in smokers are critical nodes in the executive, salience, and emotional regulation networks (Seeley et al., 2007; Williams, 2016) . Additionally, in smokers, studies have reported smaller volumes (Almeida et al., 2011; Almeida et al., 2008; Peng et al., 2018) in adults and elders, greater longitudinal volume loss over 2 years in elders (Durazzo et al., 2012) , and accelerated age-related volume loss in middleaged adults (Durazzo et al., 2013a; Durazzo et al., 2017) in cortical and subcortical regions that show atrophic changes in those with mild cognitive impairment and early-stage Alzheimer's Diseasedisease (Vemuri et al., 2010) . Correspondingly, chronic smoking during adulthood is While most MR studies have investigated the consequences of smoking on cerebral volume, fewer studies have examined smoking-related effects on cortical thickness. Cortical thickness is believed to reflect the number and density of cells in a column (Rakic, 1988; 2008) and/or represent neuronal cell body size, the number of spines and synapses, and the degree of myelination (Eickhoff et al., 2005; Fjell and Walhovd, 2010) . Cortical thickness is genetically and phenotypically distinct from cortical surface area and volume (Kremen et al., 2010; Panizzon et al., 2009; Winkler et al., 2010) , and it is related to neurocognition in healthy adults and adolescents (Choi et al., 2008; Dickerson et al., 2008; Fjell et al., 2006; Schilling et al., 2013; Walhovd et al., 2006) and those with a cocaine use disorder (Makris et al., 2008a) . Cortical thickness is reputed to be more sensitive to neurodegenerative processes than cortical volumes (Hutton et al., 2009) ; therefore, this morphometric may increase the ability to detect more subtle structural abnormalities than volumes or density measures and/or be differentially affected by addictive disorders compared to volumes and surface area (Durazzo et al., 2011b; Wang et al., 2016) . Taken together, cortical thickness may serve as a proxy for the integrity of cortical cytoarchitecture (Makris et al., 2007) . Kuhn and colleagues (Kuhn et al., 2010) reported that adult smokers had thinner left medial orbitofrontal cortex (OFC) than never-smokers. Karama and colleagues (Karama et al., 2015) reported wide-spread reduction of thickness across the cortex, with the greatest thinning in anterior frontal regions in elder active smokers relative to never smokers, after adjusting for vascular risk factors. In a sample of late adolescent/young adults, Li and associates (Li et al., 2015) reported that smokers demonstrated significant cortical thinning in the left caudal anterior cingulate cortex (ACC), right lateral OFC, left insula, left middle temporal gyrus, right inferior parietal lobule, and right parahippocampus. In the above studies, greater pack-years was associated with thinner cortices in the regions that also showed significantly thinner cortices in smokers relative to never-smokers. However, associations between regional cortical thickness and clinically relevant aspects of decision-making and impulsivity, which are key cognitive components in the initiation and maintenance of addictive disorders (Fineberg et al., 2010; Verdejo-Garcia and Bechara, 2009) , were not examined in these studies.
The risk for smoking-related diseases increases with years of smoking (CDC, 2004) , which is inextricably linked to age. In healthy adults, increasing age is associated with declines A C C E P T E D M A N U S C R I P T in regional cortical thickness (Fjell et al., 2015; Storsve et al., 2014) . In the few previous studies investigating smoking-related effects on cortical thickness, mean thickness differences were examined between smokers and never-smokers. While this approach permitted testing for the effect of smoking status (i.e., smoker vs. never-smoker) collapsed across the age range of the participants, no study specifically tested for a smoking status by age interaction. Our previous neuroimaging studies showed that, in healthy participants 25-70 years of age, smokers had both lower mean values and greater age-related declines of anterior frontal brain metabolite concentrations (N-acetylaspartate and glutamate) and hippocampal and subcortical volumes (Durazzo et al., 2016c; Durazzo et al., 2013a; Durazzo et al., 2017) . In these studies, greater cigarette pack-years was related to lower metabolite levels and smaller regional volumes. The greater age-related declines apparent in smokers suggest that chronic smoking amplified the effects of normal aging on multiple aspects of neurobiology. These neurobiological abnormalities may influence reward processing and response to smoking cessation interventions via alterations of the integrity of structural and/or functional connectivity in frontolimbic and/or frontostriatal circuitry (Froeliger et al., 2015; Hong et al., 2009; Li et al., 2017; Sutherland et al., 2013; Sutherland et al., 2016; Sweitzer et al., 2016) . Based on previous neuroimaging findings from our group and others, we predicted that adult smokers would demonstrate greater agerelated cortical thinning and lower mean thickness in anterior frontal regions that serve as nodes for the executive, salience, and emotional regulation networks (hereafter referred to as ESER regions) as well as in posterior regions that show significant atrophy in early-stage Alzheimer's Diseasedisease (hereafter referred to as AD regions). In smokers, we hypothesized that higher pack-years are related to thinner cortices in ESER and AD regions. We also predicted that poorer
performance on measures of decision-making/risk-taking and impulsivity are associated with thinner cortices in ESER regions of smokers.
Methods

Participants
Eighty-two healthy, community-dwelling participants [41 non-smokers (seven females) and 41 smokers (six females)] were recruited via electronic billboards and word-of-mouth.
Participants were between the ages of 22 and 70 (see Table 1 for demographics). Participants gave written informed consent according to the Declaration of Helsinki, and all procedures were approved by the University of California San Francisco and the San Francisco VA Medical Center.
Detailed inclusion/exclusion criteria are described elsewhere (Durazzo et al., 2011a) . In summary, participants were screened for the following: history of neurologic (e.g., seizure disorder, neurodegenerative disorder, demyelinating disorder, closed head trauma with loss of consciousness), and general medical (e.g., hypertension, myocardial infarction, Type-1 or 2 diabetes, cerebrovascular accident, any form of cancer) and psychiatric (i.e., mood, thought, anxiety, trauma and stressor-related, substance/alcohol use disorders) conditions known or suspected to influence neurocognition and/or brain neurobiology. Non-smoking participants never smoked (n = 36) or smoked less than 40 cigarettes during their lifetime and used no tobacco products for at least 10 years prior to study (n = 5). All smoking participants were actively smoking at the time of assessment, smoked at least 10 cigarettes/day for 5 years or more, and had no periods of smoking cessation greater than 1 month in the 5 years prior to study with no concurrent use of other tobacco products. No smoker was engaged in any pharmacological and/or behavioral smoking cessation program at the time of study.
Medical, psychiatric, substance, alcohol consumption and behavioral assessment
Participants completed the screening section of the Structured Clinical Interview for DSM-IV Axis I disorders, Patient Edition, Version 2.0 [SCID-I/P; (First et al., 1998) ] as well as an in-house questionnaire designed to screen for medical, psychiatric, neurological and developmental conditions that may affect neurocognition or neurobiology (see Durazzo et al., 2004) . Participants completed standardized questionnaires assessing substance use [in-house questionnaire assessing substance type, quantity and frequency of use (Abe et al., 2013) ] and lifetime alcohol consumption [Lifetime Drinking History, LDH; (Skinner and Sheu, 1982; Sobell et al., 1988) ]. From the LDH, average number of drinks per month over lifetime (one drink defined as containing 13.6 grams of pure ethanol) was calculated. Participants also completed self-report measures of depressive [(Beck Depression Inventory, BDI; (Beck, 1978) ] and anxiety symptomatology [(State-Trait Anxiety Inventory, form Y-2, STAI; (Spielberger et al., 1977) ]. (Bechara, 2007) ], a task-based measure of decision-making and risk-taking, and the Barrett (Patton et al., 1995) ], a self-report measure of aspects of trait impulsivity.
Smokers completed a measure of nicotine dependence level [Fagerström Test for Nicotine
A C C E P T E D M A N U S C R I P T Impulsivity Scale-11 [BIS-11
Magnetic Resonance Imaging (MRI) acquisition and processing
Morphological MRI data were acquired on a 4.0 Tesla Bruker MedSpec system using an 8-channel transmit-receive head coil (Siemens, Erlangen, Germany). A Magnetization Prepared Rapid Gradient (TR/TE/TI = 2300/3/950 ms, 7 o flip angle, 1.0 x 1.0 x 1.0 mm 3 resolution) sequence was used to acquire 3D sagittal T1-weighted images for morphological analyses. The publicly available FreeSurfer (v5.1) segmentation and cortical surface reconstruction methods were used to obtain thickness for 34 bilateral regions (mm) and total intracranial volume (ICV; mm 3 ) (Dale et al., 1999; Fischl and Dale, 2000; Fischl et al., 2004; Fischl et al., 1999) . All segmented subcortical and parcellated cortical T1-weighted images were visually inspected by one of the authors (TCD) for accuracy; any errors in segmentation/parcellation were manually edited, reprocessed, and reinspected as previously described (Durazzo et al., 2014c) . The final segmented subcortical and parcellated cortical volumes passed all quality requirements (Durazzo et al., 2014c) . Analyses focused on cortical components that serve as nodes for the ESER (Seeley et al., 2007; Williams, 2016) 
Statistical Analyses
Comparisons of Smokers and Non-smokers on regional ESER and AD thickness.
To test our hypothesis of greater age-related regional cortical thinning in smokers, we employed generalized linear modeling (GENLIN) and specifically tested for a smoking status (smoker vs. non-smoker) by age interaction. In preliminary analyses comparing smokers and non-smokers, no consistent pattern emerged for lateralized differences in the ROIs; therefore, results for the average of the left and right hemisphere for each ESER, AD, and Non-ESER/AD ROIs are presented. Dependent measures were ROI thickness, and covariates included age, education, BDI score, ICV, average lifetime drinks/month (smokers and non-smokers were different on education, BDI score, and average lifetime drinks/month; see Table 1 and section 3.1. below).
Although cortical thickness is reported to not show the same strong magnitude of relationships with ICV as surface area and volume (e.g., Kremen et al., 2010; Panizzon et al., 2009) , cortical thickness was significantly inversely related to ICV in our previous studies of individuals with alcohol use disorder and healthy controls (Durazzo et al., 2013b; Durazzo et al., 2011b) . Main effects and interactions between smoking status and age and follow-up t-tests (two-tailed) were considered significant at p < .05. In all previous neuroimaging-based reports with this cohort (Durazzo et al., 2016c; Durazzo et al., 2013a; Durazzo et al., 2017) , we conservatively corrected t-tests for multiple comparisons. Given our a priori predictions and our consistent findings of neurobiological and neurocognitive abnormalities in smokers in the ROIs investigated in this study, follow-up t-tests were considered statistically significant at p < .05, uncorrected. Effect (Cohen, 1988) for statistically significant differences in ROI thickness between smokers and non-smokers.
Comparisons of Smokers and Non-smokers on non-ESER/AD ROI thickness.
Smokers and Non-Smokers were compared on regions outside the specified ESER and AD ROIs to determine if smoking-related effects on cortical thickness were localized to ESER and AD ROIs or were more widely distributed. GENLIN was used for these comparisons, and, consistent with analyses of Smokers and Non-Smokers on ESER and AD ROIs, we specifically tested for a smoking status (smoker vs. non-smoker) by age interaction and employed the same covariates.
Main effects and interactions between smoking status and age and follow-up t-tests (two-tailed)
were considered significant at p < .05 in these exploratory analyses. The following cortical regions were compared: banks of superior temporal gyrus, cuneus, frontal pole, lingual, paracentral, pars opercularis, pars triangularis, pericalcarine, post central, precentral, superior parietal, superior temporal, and transverse temporal cortices.
Associations between ESER, AD, and non-ESER/AD ROI thickness and smoking
severity measures. In Smokers, associations between the ESER, AD, and Non-ESER/AD ROI thickness and cigarette pack-years (measure of exposure magnitude) and FTND score (measure of nicotine dependence level) were examined by linear regression (partial correlations reported) adjusting for age, education, and ICV. A two-tailed p < .05 was considered statistically significant, and only associations of at least moderate magnitude (i.e., r ≥ |0.30|) were reported.
Associations between ESER, AD, and Non-ESER/AD ROI thickness and decisionmaking/risk-taking and impulsivity in Smokers and Non-Smokers. Associations of ESER and AD
ROI thickness and performance on the IGT Total Score (raw score) and BIS-11 total score, attentional impulsivity, motor impulsivity, and non-planning impulsivity were separately 
Results
Participant demographics and clinical variables
Smokers and Non-Smokers were equivalent on age, sex, percent of Caucasians, and level of anxiety symptomatology. Smokers had significantly lower educational level, higher BDI scores, and consumed more average lifetime alcoholic drinks per month (all p < .05). Although statistically different between groups, the average BDI score for both groups was in the normal range (i.e., < 10) and well below the cutoff for mild depressive symptomatology (Richter et al., 1998) . Participant alcohol consumption did not approach a hazardous level [see (McKee et al., 2007; Mertens et al., 2005) ] (see Table 1 ). All females were pre-menopausal, by self-report.
Comparisons of Smokers and Non-Smokers on ESER and AD ROI cortical thickness
Models containing smoking status, age, and ICV were significant predictors of thickness in the medial OFC [ 2 (3) = 9.56, p = .023], lateral OFC [ 2 (3) = 13.5, p = .004], entorhinal Fig. 1 and 2) . BDI score was not a significant predictor of thickness in any region. The smoking status x age interactions were not significant for any ROI examined.
Comparisons of Smokers and Non-Smokers on Non-ESER and AD cortical ROI thickness
No significant smoking status x age interactions or main effects for smoking status were observed for any Non-ESER/AD ROI.
Associations of pack-years and nicotine dependence and regional thickness in
Smokers 3.4.1 ESER and AD ROIs. In Smokers, higher pack-years was related to thinner cortices in the middle temporal (r = -0.50, p = .001; see Fig. 3 ), inferior parietal (r = -0.42, p = .010), fusiform (r = -0.41, p = .013), precuneus (r = -0.37, p = .024), lateral OFC (r = -0.33, p = .047), and composite AD (r = -0.40, p = .013) ROIs. No significant associations were observed between FTND score and ESER or AD ROIs.
Non-ESER/AD ROIs.
There were no significant associations between pack-years and FTND score for any region. 
Associations of measures of decision-making and impulsivity with regional thickness in Smokers and Non-Smokers
ESER and AD ROIs. In Smokers, lower IGT Net Total Score (indicative of poorer
decision-making/lower risk-taking) was associated with thinner cortices in the superior frontal gyrus (r = 0.51, p = .005; see Fig. 4 ), caudal ACC (r = 0.44, p = .020), rostral middle frontal gyrus (r = -0.43, p = .022), and composite ESER (r = 0.43, p = .022). On the BIS-11, higher nonplanning impulsivity (r = -0.35, p = .046), motor impulsivity (r = -0.38, p = .028), and BIS-11 total score (r = -0.43, p = .022) were related to thinner rostral ACC, and higher non-planning impulsivity was associated with thinner caudal ACC (r = -0.37, p = .030). The associations between the IGT, BIS-11, and above ROIs largely showed equivalent magnitudes for the left and right hemisphere for both groups (data not shown). There were no significant relationships between IGT, BIS-11, and ESER or AD ROI thickness in Non-Smokers. 
Non
Discussion
The primary findings of this 4 Tesla quantitative MRI study were: 1) Otherwise healthy The overall pattern of findings indicates the regional cortical thinning and associations with pack-years demonstrated by this group of smokers were limited to ESER and AD ROIs.
These results are highly consistent with the few previous published studies of smoking-related effects on regional cortical thickness in non-clinical populations (Karama et al., 2015; Kuhn et al., 2010; Li et al., 2015) and also congruent with studies investigating the effects of smoking on regional brain volumes (see Durazzo et al., 2010; Pan et al., 2013; Sutherland et al., 2016) .
Contrary to predictions, smokers did not show greater age-related cortical thinning in any ROI, unlike the greater age-related decline in hippocampal and subcortical volumes (Durazzo et al., 2013a; Durazzo et al., 2017 ) and brain metabolites (Durazzo et al., 2016c) previously observed in this cohort. As this study excluded individuals with clinically significant smoking-related morbidity, it is possible that the age-related effects on cortical thickness were underestimated in this otherwise healthy cohort (Durazzo et al., 2014a) , and/or the age range was not sufficient to yield a smoking status by age interaction.
In ESER regions, Smokers showed thinning of the medial and lateral OFC and insula.
Collectively, the OFC is implicated in appraisal of stimulus saliency and representation of reward magnitude, self-monitoring, emotional and impulse regulation, and aspects of decisionmaking and executive skills (Fettes et al., 2017; Kringelbach and Rolls, 2004; Rolls and Grabenhorst, 2008) . The insula is involved in monitoring internal physiological states/sensations (i.e., interoception), adjustment of attentional control based on internal physiological states (Naqvi and Bechara, 2010; Paulus, 2007) , and is a major node in the salience network (Williams, 2016) . A double blind, placebo-controlled trial of repetitive transcranial magnetic stimulation
found that high frequency stimulation (one session/day for 13 days) to the bilateral insula and dorsolateral prefrontal cortex was associated with a smoking cessation rate of 44% immediately after treatment and 33% cessation rate in the 6 months following the treatment (Dinur-Klein et al., 2014) . In AD regions, Smokers demonstrated thinner cortices in the entorhinal, fusiform, and middle temporal gyrus as well as across the collective AD ROIs. These regions subserve aspects of face and body recognition, color processing, word recognition (left hemisphere), and declarative and spatial memory (Grill-Spector and Weiner, 2014; Kolb and Whishaw, 2009 ).
Compromised structural integrity of the ESER and AD cortical regions, as indicated by the reduced thickness, may contribute to the abnormalities observed in smokers in mood regulation, cue reactivity, impulse control, decision-making, learning and memory, executive skills (Durazzo et al., 2016c; Durazzo et al., 2010 Durazzo et al., , 2011a Fergusson et al., 2003) , and to the altered functional connectivity (Fedota and Stein, 2015) .
Greater pack-years showed moderate magnitude associations with thinner cortices in the lateral OFC, middle temporal, inferior parietal, fusiform, precuneus, and composite AD ROIs.
The lateral OFC, middle temporal, fusiform, and Composite AD thicknesses were significantly reduced in Smokers, which suggests a cigarette dose/duration-response relationship. No significant associations were observed between pack-years and thickness in areas outside the ESER and AD ROIs. Increased smoking-related cerebral oxidative stress (see Durazzo et al., 2016a; Durazzo et al., 2016b; Durazzo et al., 2014a; Durazzo et al., 2014b) and/or chronic nicotine exposure (see Durazzo et al., 2014a; Sutherland et al., 2016) In Smokers, poorer performance on the IGT (indicative of worse decision-making/greater risk-taking) was related to thinner cortices in the superior frontal gyrus, caudal ACC, rostral middle frontal gyrus, and composite ESER. These results are congruent with findings that tissue integrity of the dorsolateral and ventral medial prefrontal cortex and caudal ACC is related to performance on the IGT and other tasks/situations that require adjustment of goal-directed activity based on current environmental contingencies and anticipated future consequences (Bush et al., 2002; Clark et al., 2003; Fellows and Farah, 2005; Mega and Cummings, 1994) . Higher aspects of self-reported impulsivity were related to thinner rostral and caudal ACC, which is consistent with the role of the ACC in monitoring and regulation of behavior and emotions (Bush et al., 2000; Goodkind et al., 2015; Williams, 2016) . There were no significant associations between the IGT and BIS-11 and regional cortical thickness in Non-Smokers. The variance on the IGT and BIS-11 in Non-Smokers was relatively low, which appears to have restricted the range on these measures and likely dampened the magnitude of the associations between these measures and regional cortical thickness in this group.
This study has limitations that may affect the generalizability of the findings.
Undocumented premorbid/comorbid group differences in lifestyle or subclinical biomedical conditions (e.g., poor diet and nutrition, lack of exercise, subclinical pulmonary or cardiovascular dysfunction) and/or genetic polymorphisms may have influenced the results. Additionally, the small number of females precluded assessment of sex effects. Durazzo et al., 2016b; Durazzo et al., 2014a) . Studies with elder adults suggest that at least partial recovery of regional morphological abnormalities is possible with extended smoking cessation (Almeida et al., 2011; Karama et al., 2015) . Therefore, longitudinal research on the effects of chronic smoking on brain micro-and-macrostructural integrity, biochemistry, functional and structural connectivity, and their functional correlates is essential to inform the development of new treatment modalities to promote sustained smoking cessation (Ding et al., 2018; Durazzo et al., 2014a; Sweitzer et al., 2016) .
Conclusions
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